Helping Children Receive an Earlier Autism Diagnosis

For Parents For Providers

Earlier Diagnosis + Earlier Intervention = Better Outcomes

The NPDX ASD blood test is a new diagnostic tool that may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

About Our Autism Blood Test

Our blood test is validated by our National Institutes of Mental Health clinical study, the largest study to evaluate the metabolism of children with autism.

How Our Test Was Validated

The results of our clinical study were published in the scientific journal, Biological Psychiatry.

The Science Behind Our Test

We improve the lives of children and families living with autism spectrum disorder by providing tools for earlier diagnosis and more precise treatment.

Our Mission and Leadership

Earlier access to specialty care and treatments improve outcomes

Talk to your healthcare Provider (pediatrician, family doctor) about requesting our test for your child.

Talking to Your Provider

Print the NeuroPointDX brochure which summarizes our company and our autism test for your Provider.

The NPDX ASD Brochure

Sign-up to receive updates on our progress developing tools for autism diagnosis and treatment.

Sign-Up for Newsletters

Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Amino Acid Dysregulation Metabotypes – Biological Psychiatry article

Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder Smith AM, King JJ, West PR, Ludwig MA, Donley ELR, Burrier RE, Amaral DG. Abstract BACKGROUND: Autism spectrum disorder (ASD) is behaviorally and biologically heterogeneous and likely represents a series of conditions arising from different underlying genetic, metabolic,[…]

Posters

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Identification of Neurotransmitter-Associated and Other Metabotypes: Further Stratification of the Children’s Autism Metabolome Project (CAMP) ASD Subjects

Presented at the 2019 Annual Meeting of the International Society for Autism Research (INSAR) in Montreal, Ontario, Canada in May 2019. The Children’s Autism Metabolome Project (CAMP), ClinicalTrials.gov: NCT02548442, recruited 1,100 children for metabolomic analyses to identify altered metabolism associated with ASD. Previous research identified ASD subjects associated with branched-chain amino acid (BCAA) dysregulation. With this[…]

Metabolism Based Diagnosis and Precision Medicine for Autism Spectrum Disorders

Video of presentation at The National TACA Autism Conference – East Coast in Atlanta, Georgia, March 2019. In this video, Beth Donley shares her history as an autism mom as well as details about the NeuroPointDX NPDX ASD test, which is a blood test that can identify about 30% of children with autism spectrum disorder[…]